Skip to main content
. Author manuscript; available in PMC: 2019 Aug 1.
Published in final edited form as: Breast Cancer Res Treat. 2018 Apr 5;170(3):499–506. doi: 10.1007/s10549-018-4779-x

Fig. 1. Cell proliferation response of MCF-7aro, LET-R and RAD-R cell lines to everolimus.

Fig. 1

RAD-R cell line indicates acquired resistance while LET-R and MCF-7aro show response post 6 day treatment with everolimus. Cell proliferation was initiated upon the addition of testosterone (1nM T), and fold change of 1 was baseline at day 1 of MTT assay.